Navigation Links
Massive microRNA scan uncovers leads to treating muscle degeneration
Date:10/17/2007

Researchers have discovered the first microRNAs tiny bits of code that regulate gene activity linked to each of 10 major degenerative muscular disorders, opening doors to new treatments and a better biological understanding of these debilitating, poorly understood, often untreatable diseases. The study, to be published online this week by the Proceedings of the National Academy of Sciences, was led by Iris Eisenberg, PhD, of the Program in Genomics at Childrens Hospital Boston. Louis Kunkel, PhD, director of the Program in Genomics and an investigator with the Howard Hughes Medical Institute, was senior investigator.

The disorders include the muscular dystrophies (Duchenne muscular dystrophy, Becker muscular dystrophy, limb girdle muscular dystrophies, Miyoshi myopathy, and fascioscapulohumeral muscular dystrophy); the congenital myopathies (nemaline myopathy); and the inflammatory myopathies (polymyositis, dermatomyositis, and inclusion body myositis). While past studies have linked them with an increasing number of genes, it's still largely unknown how these genes cause muscle weakness and wasting, and, more importantly, how to translate the discoveries into treatments.

For instance, most muscular dystrophies begin with a known mutation in a master gene, leading to damaged or absent proteins in muscle cells. In Duchenne and Becker muscular dystrophies, the absent protein is dystrophin, as Kunkel himself discovered in 1987. Its absence causes muscle tissue to weaken and rupture, and the tissue becomes progressively nonfunctional through inflammatory attacks and other damaging events that arent fully understood.

The initial mutations do not explain why patients are losing their muscle so fast, says Eisenberg. There are still many unknown genes involved in these processes, as well as in the inflammatory processes taking place in the damaged muscle tissue.

She and Kunkel believe microRNAs may help provide the missing
'/>"/>

Contact: James Newton
james.newton@childrens.harvard.edu
617-919-3110
Children's Hospital Boston
Source:Eurekalert

Page: 1 2

Related biology news :

1. New plant DNA libraries provides massive boost to worlds plant researchers
2. Underlying cause of massive pinyon pine die-off revealed
3. Massive duplication of genes may solve Darwins abominable mystery about flowering plants
4. PNAS study reveals why organs fail following massive trauma
5. Massive coral death attributed to earthquake
6. Massive herds of animals found to still exist in Southern Sudan
7. Yale Scientists Find MicroRNA Regulates Ras Cancer Gene
8. Cooperation is key—a new way of looking at MicroRNA and how it controls gene expression
9. NYU, Rockefeller researchers find complexity of regulation by microRNA genes
10. MicroRNAs play a big part in gene regulation - and evolution
11. Molecular steps involved in the creation of gene-silencing microRNAs identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 20, 2014 C-Labs LLC, a ... Internet of Things (IoT), today announced the appointment of ... operating officer. Previously a strategic advisor to the firm, ... operations. Mr. Traynor is based out of the C-Labs ... reports to Chris Muench , Chief Executive Officer. ...
(Date:11/18/2014)... 18, 2014   EyeLock Inc. , a ... MorphoTrust USA (Safran), a leading U.S. ... a strategic partnership to offer comprehensive biometric identity ... (MVA), airport screening and financial services markets. ... serves consumers through a nationwide network of 1,100 ...
(Date:11/7/2014)... Dr. Debra Auguste, associate professor, biomedical engineering, in ... College of New York, have identified a molecule ... of the most aggressive forms of breast cancer. ... high mortality rate owing to aggressive proliferation and ... However, Professor Auguste,s team, discovered the overexpression of ...
Breaking Biology News(10 mins):C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 2EyeLock, MorphoTrust Form Strategic Partnership to Pursue Commercial Enterprise Deployments 3
... STM publishers, has signed publishing agreements with eight South ... With this move, Springer will be the publisher of ... its long tradition of dedication to publishing the increasing ... start publishing their journals in 2008 were signed with ...
... (NGF), as the name says, is an essential peptide ... Therefore we can imagine that this growth factor is ... recent scientific report published in the October 7 issue ... surprising and exciting discovery about this growth factor: NGF ...
... ANN ARBOR, Mich. Scientists know that inside each cell, ... job: It copies instructions from genes in the nucleus that ... cell to support our daily needs. Now researchers at the ... II also constantly scans the cells DNA for damage. When ...
Cached Biology News:Targeting nerve growth factor may cure liver cancer 2Enzyme alerts cell's powerful army to repair DNA damage 2Enzyme alerts cell's powerful army to repair DNA damage 3
(Date:12/17/2014)... December 17, 2014 Audacity, a leading ... and member of the Huntsworth Health Group, is proud ... executive team. In her role, Gonzales will serve as ... are incredibly honored to welcome a talent of Jamie’s ... CEO, Gaëtan Fraikin. “She is a proven healthcare innovation ...
(Date:12/17/2014)... SAN FRANCISCO, Calif. , Dec. 17, 2014 ... results of a Phase 2 study evaluating the ... the treatment of patients with severe, chronic itch ... current standard of care, including topical steroids and ... was percent change in Visual Analog Scale (VAS) ...
(Date:12/15/2014)... , Dec. 15, 2014 Organovo ... biology company focused on delivering breakthrough 3D bioprinting ... industry and collaborators of its exVive3D TM ... widely available in full commercial release on November ... field, resulting in several awards for innovation. ...
(Date:12/13/2014)... (PRWEB) December 13, 2014 CanDiag, Inc., ... spin-out company has changed its name to OncoTab, Inc. ... representation of where we are today,” said CEO and ... our platform’s applications beyond breast cancer diagnostics to include ... reflection of that evolution.” , Founded in 2011 by ...
Breaking Biology Technology:Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3CanDiag Inc. Expands Product Scope Under a New Name: OncoTab, Inc. 2
... Present at Rodman & Renshaw Annual Global Investment Conference -- BEIJING, Sept. 7 /PRNewswire-Asia-FirstCall/ -- ... ... --> ... var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab ...
... Plasma Protein Therapeutics Association (PPTA) recommends that the Centers ... Rule regarding reimbursement to better ensure patient access to ... Specifically, for CY 2011, CMS proposes to set ... biologicals, which include most plasma protein therapies, at average ...
... Sept. 3 The Maryland Stem Cell Research Commission ... Research Symposium in partnership with the National Institutes of ... Technology (NIST) on Wednesday, Sept. 22, 2010. The symposium, ... Science Research," will be held at the NIST main ...
Cached Biology Technology:Yongye International to Present at Rodman & Renshaw Annual Global Investment Conference 2Yongye International to Present at Rodman & Renshaw Annual Global Investment Conference 3Yongye International to Present at Rodman & Renshaw Annual Global Investment Conference 4Yongye International to Present at Rodman & Renshaw Annual Global Investment Conference 5Yongye International to Present at Rodman & Renshaw Annual Global Investment Conference 6Yongye International to Present at Rodman & Renshaw Annual Global Investment Conference 7PPTA Urges CMS for Appropriate Hospital Outpatient Reimbursement for Plasma Protein Therapies 2PPTA Urges CMS for Appropriate Hospital Outpatient Reimbursement for Plasma Protein Therapies 3Maryland Stem Cell Research Commission to Host Third Annual Maryland Stem Cell Research Symposium 2Maryland Stem Cell Research Commission to Host Third Annual Maryland Stem Cell Research Symposium 3
... for the PDS-1000 He biolistic system enables 7-10 ... standard system. It fits into the shocking chamber ... the helium shock wave over 7 microcarriers. By ... over this larger area, the system maximizes the ...
... He system uses a burst of ... nucleic acid-coated gold or tungsten microparticles ... tissues, or organelles without dependence or ... system includes helium pressure regulator, solenoid, ...
Liquid. 50 μg/ml in PBS, pH 7.4. PROTECT FROM LIGHT. A convenient form of propidium iodide useful for flow cytometry studies. RTECS SF7949600, CAS 25535-16-4, M.W. 668.4. ...
... ProteinChip arrays have been developed for ... samples. A variety of ProteinChip chemical ... according to their unique biochemical properties. ... allowing side-by-side sample comparison, and the ...
Biology Products: